Welcome to Hologic Investor Relations

 Hologic, Inc. is a leading developer, manufacturer and supplier of premium diagnostic products, medical imaging systems and surgical products. The Company’s core business units focus on diagnostics, breast health, GYN surgical, and skeletal health. With a unified suite of technologies and a robust research and development program, Hologic is dedicated to The Science of Sure.

The Company's Common Stock is listed on the Nasdaq Global Select Market under the trading symbol HOLX.

Recent News
May 11, 2016

Hologic, Inc. (Nasdaq: HOLX) announced today that the MyoSure® suite of gynecologic surgical products is expanding to include the MyoSure REACH device. The MyoSure REACH device confronts the...

May 3, 2016

Hologic, Inc. (Nasdaq: HOLX) announced today that the Company will present at these upcoming investor conferences: The Bank of America Merrill Lynch 2016 Health Care Conference in Las Vegas, NV on...

May 3, 2016

A new cervical cancer screening study demonstrates that Pap+HPV Together™ (co-testing) remains the most effective strategy for detecting high-grade cervical lesions1,2, Hologic, Inc. (Nasdaq:...

May 2, 2016

While nearly three-quarters of Americans (71%) are aware of the effects that osteoporosis can have on their health, only about half report taking any steps to prevent it,1 according to the results...

More ›